Refining evidence-based retinopathy of prematurity screening guidelines: The SCREENROP study | Zendy

Kourosh Sabri | Zendy; Sandesh Shivananda | Zendy; Forough Farrokhyar | Zendy; Alessandro Selvitella | Zendy; Bethany Easterbrook B Kin | Zendy; Wendy Seidlitz | Zendy; Shoo K. Lee | Zendy; Kaitlyn Whelan | Zendy; Prakesh S. Shah | Zendy; Jane Gardiner | Zendy; Xiang Y. Ye | Zendy; Andrew Budning | Zendy; Ian D. Clark | Zendy; Vasudha Erraguntla | Zendy; Anick Fournier | Zendy; Patrick Hamel | Zendy; Elise Héon | Zendy; Gloria Isaza-Zapata | Zendy; Christopher Lyons | Zendy; Ian Macdonald | Zendy; Inas Makar | Zendy; Peter J. Kertes | Zendy; Mark Greve | Zendy; Matthew Tennant | Zendy; Kamiar Mireskandari | Zendy; Fariba Nazemi | Zendy; Michael D. O’Connor | Zendy; Luis H. Ospina | Zendy; Victor Pegado | Zendy; Johane M. Robitaille | Zendy; Sapna Sharan | Zendy; Dayle Sigesmund | Zendy; Carlos Solarte | Zendy; Yi Ning J. Strube | Zendy; Rosanne Superstein | Zendy; Nasrin Tehrani | Zendy; Conor Mulholland | Zendy; Naeem U. Nabi | Zendy; Anne Synnes | Zendy; Joseph Ting | Zendy; Nicole Rouvinez-Bouali | Zendy; Bruno Piedbœuf | Zendy; Christine Drolet | Zendy; Valérie Bertelle | Zendy; Édith Massé | Zendy; Hala Makary | Zendy; Wendy Yee | Zendy; Adele Harrison | Zendy; Molly Seshia | Zendy; Keith J. Barrington | Zendy; Jehier Afifi | Zendy; Akhil Deshpandey | Zendy; Ermelinda Pelausa | Zendy; Kimberly Dow | Zendy; Patricia Riley | Zendy; Martine Claveau | Zendy; Khalid Aziz | Zendy; Ze Cieslak | Zendy; Zarin Kalapesi | Zendy; Koravangattu Sankaran | Zendy; Daniel Faucher | Zendy; Ruben Alvaro | Zendy; Roderick Canning | Zendy; Orlando da Silva | Zendy; Cecil Ojah | Zendy; Luis Monterrosa | Zendy; Michael Dunn | Zendy; Todd Sorokan | Zendy; Andrzej Kajetanowicz | Zendy; Chuks Nwaesei | Zendy; Carlos Fajardo | Zendy; Sahira Husain | Zendy; Sunny Xia | Zendy; Virginia Viscardi | Zendy; S.-Y. Yeh | Zendy; Laura Schneider | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Refining evidence-based retinopathy of prematurity screening guidelines: The SCREENROP study

Author(s) -

Kourosh Sabri,

Sandesh Shivananda,

Forough Farrokhyar,

Alessandro Selvitella,

Bethany Easterbrook B Kin,

Wendy Seidlitz,

Shoo K. Lee,

Kaitlyn Whelan,

Prakesh S. Shah,

Jane Gardiner,

Xiang Y. Ye,

Andrew Budning,

Ian D. Clark,

Vasudha Erraguntla,

Anick Fournier,

Patrick Hamel,

Elise Héon,

Gloria Isaza-Zapata,

Christopher Lyons,

Ian Macdonald,

Inas Makar,

Peter J. Kertes,

Mark Greve,

Matthew Tennant,

Kamiar Mireskandari,

Fariba Nazemi,

Michael D. O’Connor,

Luis H. Ospina,

Victor Pegado,

Johane M. Robitaille,

Sapna Sharan,

Dayle Sigesmund,

Carlos Solarte,

Yi Ning J. Strube,

Rosanne Superstein,

Nasrin Tehrani,

Conor Mulholland,

Naeem U. Nabi,

Anne Synnes,

Joseph Ting,

Nicole Rouvinez-Bouali,

Bruno Piedbœuf,

Christine Drolet,

Valérie Bertelle,

Édith Massé,

Hala Makary,

Wendy Yee,

Adele Harrison,

Molly Seshia,

Keith J. Barrington,

Jehier Afifi,

Akhil Deshpandey,

Ermelinda Pelausa,

Kimberly Dow,

Patricia Riley,

Martine Claveau,

Khalid Aziz,

Ze Cieslak,

Zarin Kalapesi,

Koravangattu Sankaran,

Daniel Faucher,

Ruben Alvaro,

Roderick Canning,

Orlando da Silva,

Cecil Ojah,

Luis Monterrosa,

Michael Dunn,

Todd Sorokan,

Andrzej Kajetanowicz,

Chuks Nwaesei,

Carlos Fajardo,

Sahira Husain,

Sunny Xia,

Virginia Viscardi,

S.-Y. Yeh,

Laura Schneider

Publication year - 2019

Publication title -

paediatrics and child health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.55

H-Index - 43

eISSN - 1918-1485

pISSN - 1205-7088

DOI - 10.1093/pch/pxz085

Subject(s) - retinopathy of prematurity , medicine , gestational age , pediatrics , birth weight , logistic regression , cohort , retrospective cohort study , blinding , cohort study , intensive care , neonatal intensive care unit , pregnancy , intensive care medicine , clinical trial , genetics , biology

Retinopathy of prematurity (ROP) is a potentially blinding condition affecting premature infants for which less than 10% of babies undergoing screening require treatment. This study assessed and validated predictors of developing clinically significant ROP (type 2 or worse) and ROP requiring treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research